Attached files

file filename
EX-32.2 - CERTIFICATION OF THE CHIEF FINANCIAL OFFICER PURSUANT TO 18 U.S.C. SECTION 1350 - DAYSTAR TECHNOLOGIES INCdex322.htm
EX-32.1 - CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER PURSUANT TO 18 U.S.C. SECTION 1350 - DAYSTAR TECHNOLOGIES INCdex321.htm
EX-31.1 - CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO RULE 13A-14(A) - DAYSTAR TECHNOLOGIES INCdex311.htm
EX-31.2 - CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO RULE 13A-14(A) - DAYSTAR TECHNOLOGIES INCdex312.htm

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 10-Q

 

 

(Mark One)

x QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 31, 2011

or

 

¨ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the Transition Period from             to             

Commission File No. 001-34052

 

 

DayStar Technologies, Inc.

(Exact name of registrant as specified in its charter)

 

 

 

Delaware   84-1390053

(State or other jurisdiction of

incorporation or organization)

 

(I.R.S. Employer

Identification No.)

 

1010 South Milpitas Boulevard

Milpitas, California

  95035
(Address of principal executive offices)   (Zip Code)

(408) 582-7100

(Registrant’s telephone number, including area code)

 

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  x    No  ¨

Indicate by checkmark whether the registrant has submitted electronically and posted on its corporate Web-site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).    Yes  ¨    No  ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer   ¨    Accelerated filer   ¨
Non-accelerated filer   ¨  (Do not check if a smaller reporting company)    Smaller reporting company   x

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes  ¨    No  x

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date.

 

Title of Each Class

 

Outstanding at May 13, 2011

Common Stock par value $0.01 per share   8,904,044

 

 

 


DAYSTAR TECHNOLOGIES, INC.

Quarterly Report on Form 10-Q

Quarterly Period Ended March 31, 2011

Table of Contents

 

Part I – Financial Information   

Item 1. Financial Statements

  

Balance Sheets—As of March 31, 2011 (unaudited) and December 31, 2010

     3   

Statements of Operations—For the Three Months Ended March  31, 2011 and 2010 and For the Period From July 1, 2005 (Inception of the Development Stage) to March 31, 2011 (unaudited)

     4   

Statement of Changes in Stockholders’ Equity—For the Period From July  1, 2005 (Inception of the Development Stage) to March 31, 2011 (unaudited)

     5   

Statements of Cash Flows for the Three Months Ended March  31, 2011 and 2010 and For the Period From July 1, 2005 (Inception of the Development Stage) to March 31, 2011 (unaudited)

     7   

Notes to Financial Statements (unaudited)

     8   

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

     15   

Item 3. Quantitative and Qualitative Disclosures About Market Risk

     17   

Item 4. Controls and Procedures

     17   
PART II – Other Information   

Item 1. Legal Proceedings

     18   

Item 1A. Risk Factors

     18   

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

     18   

Item 3. Defaults Upon Senior Securities

     18   

Item 4. (Removed and Reserved)

     18   

Item 5. Other Information

     18   

Item 6. Exhibits

     19   

Signatures

     20   

 

2


PART I. FINANCIAL INFORMATION

 

Item  1. Financial Statements

DAYSTAR TECHNOLOGIES, INC.

(A DEVELOPMENT STAGE ENTERPRISE)

BALANCE SHEETS

 

     March 31,
2011
    December 31,
2010
 
     (Unaudited)        
ASSETS     

Current Assets:

    

Cash and cash equivalents

   $ 23,179      $ 97,058   

Other current assets

     205,431        294,743   
                

Total current assets

     228,610        391,801   
                

Property and Equipment, at cost

     20,738,338        23,876,208   

Less accumulated depreciation and amortization

     (6,063,310     (5,658,906
                

Net property and equipment

     14,675,028        18,217,302   
                

Other Assets:

    

Other assets

     324,677        30,940   
                

Total Assets

   $ 15,228,315      $ 18,640,043   
                
LIABILITIES AND STOCKHOLDERS’ EQUITY     

Current Liabilities:

    

Accounts payable and accrued expenses

   $ 4,778,760      $ 6,943,711   

Notes and capital leases payable, current portion, net of discount of $70,336 and $664,835, respectively

     4,234,664        4,590,165   
                

Total current liabilities

     9,013,424        11,533,876   

Long-Term Liabilities:

    

Conversion feature

     245,898        3,854,272   
                

Total long-term liabilities

     245,898        3,854,272   

Commitments and Contingencies

     —          —     

Stockholders’ Equity:

    

Preferred stock, $.01 par value; 3,000,000 shares authorized; 0 shares issued and outstanding

     —          —     

Common stock, $.01 par value; 120,000,000 shares authorized; 8,416,054 and 6,484,516 shares issued and outstanding at March 31, 2011 and December 31, 2010, respectively

     84,161        64,845   

Additional paid-in capital

     156,353,377        153,272,626   

Accumulated deficit

     (10,145,391     (10,145,391

Deficit accumulated during the development stage

     (140,323,154     (139,940,185
                

Total stockholders’ equity

     5,968,993        3,251,895   
                

Total Liabilities and Stockholders’ Equity

   $ 15,228,315      $ 18,640,043   
                

See accompanying notes to these financial statements.

 

3


DAYSTAR TECHNOLOGIES, INC.

(A DEVELOPMENT STAGE ENTERPRISE)

STATEMENTS OF OPERATIONS

(Unaudited)

 

          

For the Period

from July 1, 2005

(Inception of the

Development Stage)

to March 31,

 
     For the Three Months Ended
March 31,
   
     2011     2010     2011  

Revenue:

      

Product revenue

   $ —        $ —        $ 3,528   

Research and development contract revenue

     —          —          615,000   
                        

Total revenue

     —          —          618,528   

Costs and Expenses:

      

Research and development

     606,565        2,488,828        61,126,453   

Selling, general and administrative

     1,232,187        2,242,266        36,357,657   

Restructuring

     850,000        —          13,883,693   

Depreciation and amortization

     404,786        729,361        14,476,894   
                        

Total costs and expenses

     3,093,538        5,460,455        125,844,697   

Other Income (Expense):

      

Other income

     —          9,375        2,228,332   

Interest expense

     (233,787     (122,226     (3,306,570

Amortization of note discount and financing costs

     (705,812     (975,231     (16,848,267

Gain on derivative liabilities

     3,650,168        406,179        13,820,256   

Loss on extinguishment of debt

     —          —          (10,990,736
                        

Total other income (expense)

     2,710,569        (681,903     (15,096,985
                        

Net Loss

   $ (382,969   $ (6,142,358   $ (140,323,154
                        

Weighted Average Common Shares Outstanding (Basic And Diluted)

     7,827,217        3,807,854     
                  

Net Loss Per Share (Basic and Diluted)

   $ (0.05   $ (1.61  
                  

See accompanying notes to these financial statements.

 

4


DAYSTAR TECHNOLOGIES, INC.

(A DEVELOPMENT STAGE ENTERPRISE)

STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY

FOR THE PERIOD FROM JULY 1, 2005 (INCEPTION OF THE DEVELOPMENT STAGE) TO MARCH 31, 2011

(Unaudited)

 

     Common Stock      Class B
Common Stock
    Additional
Paid-In
Capital
    Deferred
Equity Based
Compensation
    Accumulated
Deficit
    Deficit
Accumulated
During the
Development
Stage
    Total  
     Shares      Amount      Shares     Amount            

BALANCES , July 1, 2005

     564,806       $ 5,648         3,222      $ 32      $ 22,488,624      $ (110,770   $ (10,145,391   $ —        $ 12,238,143   

Exercise of warrants and stock options, 7/05 - 12/05 at $54.00—$74.00 per share

     132,305         1,323         —          —          7,218,879        —          —          —          7,220,202   

Conversion of Class B common stock

     6,444         64         (3,222     (32     (32     —          —          —          —     

Share-based compensation

     4,306         43         —          —          412,257        (292,940     —          —          119,360   

Net loss

     —           —           —          —          —          —          —          (3,904,151     (3,904,151
                                                                          

BALANCES, December 31, 2005

     707,861       $ 7,078         —        $ —        $ 30,119,728      $ (403,710   $ (10,145,391   $ (3,904,151   $ 15,673,554   

Reclassification upon adoption of SFAS 123(R)

     —           —           —          —          (403,710     403,710        —          —          —     

Exercise of warrants and stock options, 1/06, 3/06 & 9/06 at $18.54—$67.50 per share

     14,757         148         —          —          671,725        —          —          —          671,873   

Share-based compensation

     19,674         197         —          —          1,322,523        —          —          —          1,322,720   

Beneficial conversion feature on convertible note

     —           —           —          —          1,223,842        —          —          —          1,223,842   

Shares issued in payment of principal and interest on convertible note, 8/06 -12/06

     127,004         1,270         —          —          7,376,889        —          —          —          7,378,159   

Warrants issued for placement of convertible note at $48.42 per share

     —           —           —          —          140,419        —          —          —          140,419   

Net loss

     —           —           —          —          —          —          —          (20,441,201     (20,441,201
                                                                          

BALANCES, December 31, 2006

     869,296       $ 8,693         —        $ —        $ 40,451,416      $ —        $ (10,145,391   $ (24,345,352   $ 5,969,366   

Exercise of warrants and stock options, 1/07, 3/07, 6/07, 9/07 & 11/07 at $18.00—$31.05 per share

     57,578         576         —          —          3,173,741        —          —          —          3,174,317   

Share-based compensation

     21,826         218         —          —          4,089,826        —          —          —          4,090,044   

Issuance of shares pursuant to offering, 2/07 at $18.00 per share

     277,777         2,778         —          —          4,997,222        —          —          —          5,000,000   

Issuance of shares pursuant to secondary offering, 10/07 at $38.25 per share, net of offering costs

     1,916,668         19,166         —          —          67,875,752        —          —          —          67,894,918   

 

5


    Common Stock     Class B
Common
Stock
    Additional
Paid-In Capital
    Deferred
Equity Based
Compensation
    Accumulated
Deficit
    Deficit
Accumulated
During the
Development
Stage
    Total  
    Shares     Amount     Shares     Amount            

Shares issued in payment of principal and interest on convertible note, 1/07 at $13.41 per share and 2/07 at $18.00 per share

    430,598        4,306        —          —          7,322,619        —          —          —          7,326,925   

Loss on extinguishment due to excess of fair market value of shares issued over issuance price

    —          —          —          —          5,369,278        —          —          —          5,369,278   

Shares issued for placement of note and offering 3/07 at $18.00 per share

    50,841        508        —          —          2,397,163        —          —          —          2,397,671   

Net loss

    —          —          —          —          —          —          —          (36,142,861     (36,142,861
                                                                       

BALANCES, December 31, 2007

    3,624,584      $ 36,245        —        $ —        $ 135,677,017      $ —        $ (10,145,391   $ (60,488,213   $ 65,079,658   

Exercise of stock options, 6/08 at $28.26 per share

    178        2        —          —          5,022        —          —          —          5,024   

Share-based compensation

    90,667        906        —          —          4,794,222        —          —          —          4,795,128   

Net loss

    —          —          —          —          —          —          —          (26,330,271     (26,330,271
                                                                       

BALANCES , December 31, 2008

    3,715,429      $ 37,153        —        $ —        $ 140,476,261      $ —        $ (10,145,391   $ (86,818,484   $ 43,549,539   

Share-based compensation

    51,861        519        —          —          4,133,012        —          —          —          4,133,531   

Warrants issued in connection with convertible note at $4.50 per share

    —          —          —          —          497,578        —          —          —          497,578   

Net loss

    —          —          —          —          —          —          —          (25,040,028     (25,040,028
                                                                       

BALANCES, December 31, 2009

    3,767,290      $ 37,672        —        $ —        $ 145,106,851      $ —        $ (10,145,391   $ (111,858,512   $ 23,140,620   
                                                                       

Exercise of warrants, 7/10 & 10/10 at $0.90 per share

    66,667        667        —          —          59,762        —          —          —          60,429   

Share-based compensation

    693,540        6,934        —          —          4,662,142        —          —          —          4,669,076   

Warrants issued in connection with convertible note at $2.70 - $4.50 per share

    —          —          —          —          704,481        —          —          —          704,481   

Shares issued in settlement of liabilities at $1.54 - $1.85 per share

    1,927,232        19,272        —          —          2,734,340        —          —          —          2,758,662   

Reverse split adjustment

    29,787        300        —          —          —          —          —          —          300   

Net loss

    —          —          —          —          —          —          —          (28,081,673     (28,081,673
                                                                       

BALANCES, December 31, 2010

    6,484,516      $ 64,845        —        $ —        $ 153,272,626      $ —        $ (10,145,391   $ (139,940,185   $ 3,251,895   
                                                                       

Share-based compensation

    —         —         —         —         932,753        —         —         —         932,753   

Warrants issued in connection with convertible note at $1.55 per share

    —          —          —          —          69,520        —          —          —          69,520   

Conversion of notes payable and accrued interest at $0.90 per share

    1,386,438        13,864        —          —          1,233,930        —          —          —          1,247,794   

Shares issued in settlement of liabilities at $1.55 - $1.57 per share

    545,100        5,452        —          —          844,548        —          —          —          850,000   

Net loss

    —          —          —          —          —          —          —          (382,969     (382,969
                                                                       

BALANCES, March 31, 2011

    8,416,054      $ 84,161        —        $ —        $ 156,353,377      $ —        $ (10,145,391   $ (140,323,154   $ 5,968,993   
                                                                       

See accompanying notes to these financial statements.

 

6


DAYSTAR TECHNOLOGIES, INC.

(A DEVELOPMENT STAGE ENTERPRISE)

STATEMENTS OF CASH FLOWS

(Unaudited)

 

     For the Three Months Ended
March 31,
   

For the Period

from July 1, 2005

(Inception of the

Development Stage)

to March 31,

 
     2011     2010     2011  

Cash Flows from Operating Activities:

      

Net loss

   $ (382,969   $ (6,142,358   $ (140,323,154

Adjustments to reconcile net loss to cash used in operating activities:

      

Depreciation and amortization

     404,786        729,361        14,476,894   

Share-based compensation

     932,753        2,138,641        20,200,667   

Non-cash interest

     233,787        122,226        2,546,171   

Amortization of note discount and non-cash financing costs

     705,812        975,231        16,271,569   

Gain on derivative liabilities

     (3,650,168     (406,179     (13,820,256

Non-cash restructuring

     850,000       —          11,881,895   

Loss on sale of fixed assets

     —          —          389,784   

Loss on extinguishment of debt

     —          —          10,990,736   

Changes in operating assets and liabilities:

      

Other assets

     89,312        (162,776     (273,403

Accounts payable and accrued expenses

     542,808        1,412,591        7,527,337   

Deferred rent

     —          79,224        1,595,239   

Deferred revenue

     —          —          217,618   
                        

Net cash used in operating activities

     (273,879     (1,254,039     (68,318,903

Cash Flows from Investing Activities:

      

Purchase of investments

     —          —          (71,957,732

Proceeds from sale of investments

     —          —          72,662,973   

Purchase of equipment and improvements

     —          —          (42,570,127

Proceeds from sale of assets

     —          —          2,035,280   
                        

Net cash used in investing activities

     —          —          (39,829,606

Cash Flows from Financing Activities:

      

Proceeds from sale of stock

     —          —          78,312,500   

Proceeds from issuance of notes

     200,000        1,250,000        29,455,000   

Payments on notes and capital leases

     —          —          (11,495,310

Cost of financing

     —          —          (6,342,379

Proceeds from exercise of warrants and stock options

     —          —          8,870,549   
                        

Net cash provided by (used in) financing activities

     200,000        1,250,000        98,800,360   
                        

Decrease in cash and cash equivalents

     (73,879     (4,039     (9,348,149

Cash and cash equivalents, beginning of period

     97,058        17,320        9,371,328   
                        

Cash and cash equivalents, end of period

   $ 23,179      $ 13,281      $ 23,179   
                        

Supplemental Cash Flow Information:

      

Cash paid for interest

   $ —        $ —       
                  

Non-Cash Transactions:

      

Principal and interest payments on convertible notes, in common stock

   $ 1,247,794      $ —       
                  

Beneficial conversion feature on convertible note

   $ 41,794      $ 147,259     
                  

Shares issued for settlement of liabilities

   $ 850,000      $ —       
                  

Accrued property & equipment

   $ —        $ 11,682,467     
                  

See accompanying notes to these financial statements.

 

7


DAYSTAR TECHNOLOGIES, INC.

(A DEVELOPMENT STAGE ENTERPRISE)

NOTES TO FINANCIAL STATEMENTS

(Unaudited)

1. Organization and Nature of Operations

DayStar Technologies, Inc. (the “Company”) is a development stage enterprise that was formed in 1997 for the purpose of developing, manufacturing and marketing innovative products to the solar photovoltaic (“PV”) industry. From its inception, the Company has focused primarily on thin film copper indium gallium di-selenide (“CIGS”) solar products. The Company has developed a proprietary one-step sputter deposition process and manufactured a commercial scale deposition tool to apply high efficiency CIGS material over large area glass substrates in a continuous fashion. The Company intends to integrate this tool with commercially available thin film manufacturing equipment which will provide a critically differentiated manufacturing process to produce low-cost monolithically integrated, CIGS-on-glass modules that address the grid-tied, ground-based PV market. The Company is pursuing a strategy to manufacture its CIGS modules offshore and is in discussions with potential partners to implement this strategy.

Certain information and note disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) have been omitted from these condensed unaudited financial statements. These condensed unaudited financial statements should be read in conjunction with the financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2010. The condensed balance sheet as of December 31, 2010 has been derived from audited financial statements. The results of operations for the three months ended March 31, 2011 and 2010 are not necessarily indicative of the operating results for the full year.

In the opinion of management, all adjustments, consisting only of normal recurring accruals, have been made to present fairly the Company’s financial position at March 31, 2011 and the results of its operations and its cash flows for the three months ended March 31, 2011 and 2010 and for the period from July 1, 2005 (Inception of the Development Stage) to March 31, 2011.

Reverse Stock Split — On April 23, 2010, the Company’s shareholders approved a reverse stock split of its issued and outstanding common shares in the range of one-for-five to one-for-nine, with the final ratio to be selected by the Company’s Board of Directors. The total authorized shares of common stock remained unchanged at 120,000,000. The Board of Directors selected a ratio of one-for-nine and the reverse stock split was effective on May 11, 2010. Trading of the Company’s common stock on the NASDAQ Capital Market on a split-adjusted basis began at the open of trading on May 12, 2010. The reverse stock split affected all shares of the Company’s common stock, as well as options to purchase the Company’s common stock and other equity incentive awards, as well as convertible debt instruments and warrants that were outstanding immediately prior to the effective date of the reverse stock split. All references to common shares and per-share data for prior periods have been retroactively restated to reflect the reverse stock split as if it had occurred at the beginning of the earliest period presented.

2. Liquidity and Future Operations

The Company’s financial statements for the year ended December 31, 2010 and for the three months ended March 31, 2011 have been prepared on a going concern basis, which contemplates the realization of assets and the settlement of liabilities and commitments in the normal course of business. The Company is in the development stage, and as such, has historically reported net losses, including a net loss of $0.4 million for the three months ended March 31, 2011. The Company anticipates it will continue to incur losses in the future as it commercializes its product. As noted herein, as a result of the Company’s current liquidity, there is substantial doubt as to its ability to continue as a going concern. In order to continue operations, pursue offshore manufacturing partners and commence commercial shipments of its product, the Company requires immediate and substantial additional capital beyond its current cash on hand.

In order to address its current financial requirements on February 2, 2011, the Company entered into a Securities Purchase Agreement (the “Purchase Agreement”) with Socius CG II, Ltd. (the “Investor” or “Socius”). Pursuant to the terms of the Purchase Agreement, the Company has the right over a term of two years, subject to certain conditions, to demand through separate tranche notices that the Investor purchase up to a total of $5.0 million of Series B preferred stock.

The Company is pursuing a strategy to manufacture its CIGS modules offshore and is in discussions with potential partners to commercialize its product through long-term strategic investments and partnerships. Those potential partnerships, if consummated, could include joint ventures, licensing agreements, contract manufacturing agreements, a merger with or an acquisition of DayStar. Although the Company continues to seek strategic investors or partners, in light of its current cash position, the Company may in the near term be forced to cease operations. The Company has implemented cost savings measures to limit its cash outflows while pursuing strategic investments and partnerships.

 

8


An inability to raise additional funding in the very near term may cause the Company to file a voluntary petition for reorganization under the United States Bankruptcy Code, liquidate assets, and/or pursue other such actions that could adversely affect future operations. Given current market conditions and available opportunities, there is substantial doubt as to the Company’s ability to complete a financing in the time frame required to remain in operation. A wide variety of factors relating to the Company and external conditions could adversely affect its ability to secure additional funding and the terms of any funding that it secures.

3. Significant Accounting Policies

Cash Equivalents—The Company considers all highly liquid debt securities purchased with an original maturity of three months or less to be cash equivalents. The Company’s cash and cash equivalents are maintained with major financial institutions within the United States and at times the balances with these institutions exceed the amount of federal insurance coverage on such deposits.

Property and Equipment—Property and equipment is stated at cost. Depreciation is computed using straight-line and an accelerated method over estimated useful lives of 3 to 10 years. Expenditures for maintenance and repairs, which do not materially extend the useful lives of property and equipment, are charged to operations as incurred. When property or equipment is retired or otherwise disposed of, the property accounts are relieved of costs and accumulated depreciation and any resulting gain or loss is recognized.

Revenue Recognition—The Company recognizes revenue in accordance with the FASB ASC 605 Revenue Recognition and Securities and Exchange Commission (the “SEC”)’s Staff Accounting Bulletin No. 104, “Revenue Recognition” (“SAB 104”) which require that four basic criteria must be met before revenue can be recognized: (1) persuasive evidence of an arrangement exists; (2) delivery has occurred or services rendered; (3) the seller’s price to the buyer is fixed and determinable; and (4) collectability is reasonably assured. Since inception of the development stage on July 1, 2005, the Company has earned minimal amounts of product revenue.

Since inception of the development stage on July 1, 2005, the principal source of revenue for the Company has been from government funded research and development contracts and grants. Grant revenue is recognized when the Company fulfills obligations as set forth under the grant. Terms of the grant reflected in the accompanying financial statements require the Company to maintain specified employment criteria over a five year period. If the Company fails to meet the specified criteria, it must repay the unearned portion of the grant. As a result, the Company reported a liability of $520,000 and $420,000 at March 31, 2011 and December 31, 2010, respectively.

Research and development contract revenue is recognized as the Company meets milestones as set forth under the contract. The Company recognized no revenue for the three months ended March 31, 2011 and 2010, respectively.

Research and Development Costs—Research and development costs are expensed as incurred. Funds obtained from government agencies that represent a cost reimbursement activity are reflected as reductions of Research and Development expenses.

Use of Estimates—The preparation of the Company’s financial statements in conformity with generally accepted accounting principles requires the Company’s management to make estimates and assumptions that affect the amounts reported in these financial statements and accompanying notes. Significant estimates include the useful lives of the Company’s property and equipment, the life and realization of the Company’s capitalized costs associated with its patents and the Company’s valuation allowance associated with its deferred tax asset. Actual results could differ from those estimates.

Share-Based Compensation—The Company follows the provisions of FASB ASC 718 Compensation—Stock Compensation, which requires the measurement and recognition of compensation expense for all share-based payment awards to employees and directors based on estimated fair values. Additionally, the Company follows the SEC’s Staff Accounting Bulletin No. 107 “Share-Based Payment” (“SAB 107”), as amended by Staff Accounting Bulletin No. 110 (“SAB 110”), which provides supplemental application guidance based on the views of the SEC. The Company estimates the expected term, which represents the period of time from the grant date that the Company expects its stock options to remain outstanding, using the simplified method as permitted by SAB 107 and SAB 110. Under this method, the expected term is estimated as the mid-point between the time the options vest and their contractual terms. The Company continues to apply the simplified method because it does not have sufficient historical exercise data to provide a reasonable basis upon which to estimate the expected terms due to the limited period of time its equity shares have been publicly traded and the limited number of its options which have so far vested and become eligible for exercise.

 

9


Share-based compensation expense for the three months ended March 31, 2011 and 2010 was as follows:

 

     For the Three Months
Ended March 31,
 
     2011      2010  

Share-based compensation:

     

Selling, general and administrative

   $ 637,421       $ 1,419,790   

Research and development

     295,332         718,851   
                 

Total share-based compensation

   $ 932,753       $ 2,138,641   
                 

During the three months ended March 31, 2011, the Company granted options to purchase 335,000 shares of common stock at an exercise price of $1.55 - $1.71 per share, all with a contractual life of ten years. Options to purchase 225,185 shares of common stock were forfeited during the three months ended March 31, 2011. During the three months ended March 31, 2011 there were restricted stock units granted to purchase 350,000 shares of common stock and there were no restricted stock units forfeited.

Subsequent to March 31, 2011 and through the date of this filing, there were no options to purchase common stock granted and there were restricted stock units granted to purchase 10,000 shares of common stock. There were no options or restricted stock units forfeited subsequent to March 31, 2011 and through the date of this filing.

Reclassifications —Certain reclassifications have been made to the 2010 financial statements to conform to the 2011 presentation. Such reclassifications had no impact on net loss.

Impact of Recently Issued Accounting Pronouncements—

In January 2010, the FASB issued ASU 2010-06, Fair Value Measurements and Disclosures (Topic 820)—Improving Disclosures about Fair Value Measurements. This ASU requires new disclosures and clarifies certain existing disclosure requirements about fair value measurements. ASU 2010-06 requires a reporting entity to disclose significant transfers in and out of Level 1 and Level 2 fair value measurements, to describe the reasons for the transfers and to present separately information about purchases, sales, issuances and settlements for fair value measurements using significant unobservable inputs. ASU 2010-06 is effective for interim and annual reporting periods beginning after December 15, 2009, except for the disclosures about purchases, sales, issuances and settlements in the roll forward of activity in Level 3 fair value measurements, which is effective for interim and annual reporting periods beginning after December 15, 2010; early adoption is permitted. The adoption of ASU 2010-06 on January 1, 2010 (with the exception of the disclosures about purchases, sales, issuances and settlements in the roll forward of activity in Level 3 fair value measurements) did not have a material impact on the Company’s financial statements. The adoption of the disclosure requirements about purchases, sales, issuances and settlements in the roll forward of activity in Level 3 fair value measurements effective January 1, 2011 did not have a material impact on the Company’s financial statements.

In December 2010, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) 2010-28, When to Perform Step 2 of the Goodwill Impairment Test for Reporting Units with Zero or Negative Carrying Amounts. This ASU amends guidance for Step 1 of the goodwill impairment test for reporting units with zero or negative carrying amounts. For those reporting units, an entity is required to perform Step 2 of the goodwill impairment test if it is more likely than not that a goodwill impairment exists. ASU 2010-28 is effective for fiscal years and interim periods beginning after December 15, 2010, with early adoption not permitted. The adoption of ASU 2010-28 during the three months ended March 31, 2011 did not have a material impact the Company’s financial statements.

In December 2010, the FASB issued ASU 2010-29, Disclosure of Supplementary Pro Forma Information for Business Combinations. This ASU specifies that if a public company presents comparative financial statements, the entity should only disclose revenue and earnings of the combined entity as though the business combination(s) that occurred during the current year had occurred as of the beginning of the comparable prior annual reporting period. ASU 2010-29 is effective prospectively for business combinations for which the acquisition date is on or after the beginning of the first annual reporting period beginning on or after December 15, 2010, with early adoption permitted. The adoption of ASU 2010-29 during the three months ended March 31, 2011 did not have a material impact on the Company’s financial statements.

 

10


4. Secured Convertible Promissory Notes and Warrants

Beginning in September 2009, the Company has entered into a series of agreements with various lenders (the “Lenders”) to provide bridge financing to the Company in exchange for convertible notes and warrants. These notes (the “Notes”) each contain terms of six months, are secured by all assets of the Company, and accrue interest at rates of between 8 – 10% per annum. The Lenders may, at their option at any time prior to payment in full of the Notes, elect to convert all or any part of the entire outstanding principal amount of the Notes plus the accrued interest on the then outstanding balance into shares of the Company’s common stock at the conversion price specified in each of the Notes (subject to adjustment in the event of any stock splits, stock dividends or other recapitalization of common stock subsequent to the date of such sale or issuance). If between the date of the Notes and such conversion, the Company issues or sells any shares of capital stock, other than certain excluded securities (a “Future Issuance”), at a per share price below the original conversion price specified in the Notes, then the conversion price of the Notes will be reduced to the price of such Future Issuance. As of March 31, 2011, the aggregate principal balance of all outstanding Notes was $4,305,000 and the Notes were convertible into 4,657,889 shares of common stock.

The Notes’ conversion features were determined to be embedded derivative liabilities and therefore were bifurcated from the Notes and recorded as a discount to the Notes at their fair value at issuance and are required to be adjusted to fair value at the end of each reporting period. The change in fair value of the conversion features, calculated using the Black Scholes model, is recorded as a gain or loss on derivative liabilities. The conversion feature fair values at March 31, 2011 and December 31, 2010 were $245,898 and $3,854,272, respectively. The change in fair value of the conversion features during the three months ended March 31, 2011 and 2010 resulted in a gain on derivative liabilities of $3,650,168 and $344,072, respectively.

The proceeds remaining, if any, after allocation to the conversion features are allocated on a relative fair value basis between the Notes and the warrants and the amounts allocated to the warrants, calculated using the Black Scholes model, are recorded as additional note discount. The discount attributable to the issuance date aggregate fair value of the conversion features and warrants, is being amortized using the effective interest method over the terms of the Notes. During the three months ended March 31, 2011 and 2010, $705,812 and $921,027, respectively, of this discount was amortized to expense.

The warrants issued in connection with these Notes are exercisable upon issuance (with the exception of the warrants issued to Dynamic Worldwide Solar Energy, LLC) and entitle the Lenders to purchase up to 5,528,740 shares of common stock at exercise prices ranging from $1.25 – $1.70 per share, as adjusted for standard anti-dilution provisions and are exercisable for a period of 2 – 7 years from their respective issuance dates.

The following table summarizes the pertinent details of the outstanding notes and warrants as of March 31, 2011.

 

Lender

   Principal Amount      Discount      Note Payable
(net of discount)
     Note Conversion
Shares Issuable
     Conversion
Price
     Warrants      Warrant
Exercise
Price
 

Peter Lacey(1)

   $ 3,075,000       $ —         $ 3,075,000         3,416,668       $ 0.90         724,074       $ 1.25   

Peter Lacey(1)

                    2,692,594       $ 1.70   

Peter Lacey(1)

     50,000         —           50,000         N/A         N/A         N/A         N/A   

Michael Moretti

     750,000         —           750,000         833,335       $ 0.90         833,335       $ 1.25   

Michael Moretti

     150,000         70,336         79,664         96,775       $ 1.55         193,550       $ 1.55   

John Gorman

     100,000         —           100,000         111,111       $ 0.90         666,667       $ 1.25   

Richard Schottenfeld

     100,000         —           100,000         111,111       $ 0.90         111,111       $ 1.25   

William Steckel(2)

     30,000         —           30,000         33,333       $ 0.90         11,112       $ 1.25   

Robert Weiss(3)

     50,000         —           50,000         55,556       $ 0.90         55,556       $ 1.25   

Dynamic Worldwide Solar Energy, LLC.

     —           —           —           —           —           240,741       $ 1.25   
   $ 4,305,000       $ 70,336       $ 4,234,664         4,657,889            5,528,740      

 

11


The following table summarizes the pertinent details of the outstanding notes and warrants as of December 31, 2010.

 

Lender

   Principal Amount      Discount      Note Payable
(net of  discount)
     Note Conversion
Shares  Issuable
     Conversion
Price
     Warrants      Warrant
Exercise
Price
 

Peter Lacey(1)

   $ 3,075,000       $ 365,676       $ 2,709,324         3,416,668       $ 0.90         724,074       $ 1.25   
                    2,692,594       $ 1.70   

Michael Moretti

     750,000         89,189         660,811         833,335       $ 0.90         833,335       $ 1.25   

John Gorman

     700,000         83,243         616,757         777,778       $ 0.90         777,778       $ 1.25   

William Steckel(2)

     30,000         3,568         26,432         33,333       $ 0.90         11,112       $ 1.25   

Robert Weiss(3)

     50,000         5,946         44,054         55,556       $ 0.90         55,556       $ 1.25   

Dynamic Worldwide Solar Energy, LLC.

     650,000         117,213         532,787         722,222       $ 0.90         240,741       $ 1.25   
   $ 5,255,000       $ 664,835       $ 4,590,165         5,838,892            5,335,190      

 

(1) Mr. Lacey is Chairman of the Board of Directors for the Company and currently serving as the Company’s Interim President and Chief Executive Officer.
(2) Mr. Steckel is a Director of the Company and the former Chief Executive Officer and Chief Financial Officer.
(3) Mr. Weiss is the Company’s Chief Technology Officer.

In January 2011, Dynamic Worldwide Solar Energy, LLC converted its entire outstanding principal balance of $650,000 as well as the accrued interest thereon into shares of the Company’s common stock, and John Gorman converted $500,000 of his outstanding principal balance as well as the accrued interest thereon into shares of the Company’s common stock. Additionally, John Gorman transferred $100,000 of his remaining balance to Richard Schottenfeld.

5. Derivative Liabilities

As described in Note 4 Secured Convertible Promissory Notes and Warrants, the Company is accounting for the conversion features in its secured convertible notes as embedded derivative liabilities. The Company currently does not use hedging contracts to manage the risk of its overall exposure to interest rate and foreign currency changes. The conversion features are not considered hedging instruments.

The conversion feature liability on the balance sheet at March 31, 2011 and 2010, and the change in the liability for the three months ended March 31, 2011 and 2010 is summarized as follows:

 

     Conversion
Feature
Liability
 

Balance, December 31, 2009

   $ 251,618   

New debt issuances

     147,260   

Change in fair value

     (344,072 )
        

Balance, March 31, 2010

   $ 54,806   
        

Balance, December 31, 2010

   $ 3,854,272   

New debt issuances

     41,794   

Change in fair value

     (3,650,168 )
        

Balance, March 31, 2011

   $ 245,898   
        

In accordance with ASC 820, the following table represents the Company’s fair value hierarchy for its financial liabilities measured at fair value on a recurring basis as of March 31, 2011 and December 31, 2010. There were no financial assets subject to the provisions of ASC 820 as of March 31, 2011 and 2010:

 

     Level 1      Level 2            Level 3                  Total        

Financial liabilities at March 31, 2011:

           

Conversion feature

   $ —         $ —         $ 245,898       $ 245,898   
                                   
   $ —         $ —         $ 245,898       $ 245,898   
                                   

Financial liabilities at December 31, 2010:

           

Conversion feature

   $ —         $ —         $ 3,854,272       $ 3,854,272   
                                   
   $ —         $ —         $ 3,854,272       $ 3,854,272   
                                   

 

12


6. Funding Commitment

On February 2, 2011 the Company entered into a Securities Purchase Agreement (the “Purchase Agreement”) with Socius CG II, Ltd. (the “Investor” or “Socius”). Pursuant to the terms of the Purchase Agreement, the Company has the right over a term of two years, subject to certain conditions, to demand through separate tranche notices that the Investor purchase up to a total of $5.0 million of Series B preferred stock.

Under the Purchase Agreement, in connection with each tranche, Socius will receive the right (the “Investment Right”) to purchase an amount of shares of our common stock equal in value to the amount of the tranche at a per share price equal to the closing bid price of the common stock on the date preceding our delivery of the tranche notice (the “Investment Price”). The Investment Right will be automatically exercised for shares of common stock at the time of each tranche. In addition, in connection with each tranche notice, a portion of a warrant issued to Socius under the Purchase Agreement with an aggregate exercise price equal to 35% of the amount of the tranche will vest and immediately be exercised at a per share price equal to the Investment Price.

Socius may pay for the shares it elects to purchase under the investment right at its option, in cash or a secured promissory note. Socius may pay for the shares it elects to purchase under the warrant at its option, in cash or a secured promissory note. Any such promissory note will bear interest at 2.0% per year and be secured by securities owned by Socius with a fair market value equal to the principal amount of the promissory note. The entire principal balance and interest on the promissory note is due and payable on the fourth anniversary of the date of the promissory note, and may be applied by the Company toward the redemption of shares of Series B preferred stock held by Socius.

Holders of Series B Preferred Stock will be entitled to receive dividends, which will accrue in shares of Series B Preferred Stock on an annual basis at a rate equal to 10% per annum from the issuance date. Accrued dividends will be payable upon redemption of the Series B Preferred Stock or upon the liquidation, dissolution or winding up of the Company. The Series B Preferred Stock ranks, with respect to dividend right and upon liquidation:

 

   

Senior to the Company’s common stock and any other series or class of preferred stock other than a class or series of preferred stock intended to be listed for trading; and

 

   

Junior to all existing and future indebtedness of the company and any class or series of preferred stock intended to be listed for trading.

The Series B Preferred Stock has a liquidation preference per share equal to the original price per share thereof plus all accrued dividends thereon (the “Liquidation Value”), and is subject to repurchase by the Company following the consummation of certain fundamental transactions by the Company. Upon or after the fourth anniversary of the applicable issuance date, the Company has the right, at its option, to redeem all or a portion of the shares of Series B Preferred Stock at the Liquidation Value. The Company also has the right, at its option, to redeem all or a portion of the shares of Series B Preferred Stock, at a price per share equal to: (i) 136% of the Liquidation Value if redeemed on or after the applicable issuance date but prior to the first anniversary of the applicable issuance date, (ii) 127% of the Liquidation Value if redeemed on or after the first anniversary but prior to the second anniversary of the applicable issuance date, (iii) 118% of the Liquidation Value if redeemed on or after the second anniversary but prior to the third anniversary of the applicable issuance date, and (iv) 109% of the Liquidation Value if redeemed on or after the third anniversary but prior to the fourth anniversary of the applicable issuance date.

Under the terms of the Purchase Agreement, the Company is obligated to pay Socius a commitment fee for committing to purchase the Series B Preferred Stock in the form of shares of common stock or cash, at the Company’s option. The amount of the commitment fee will be the number of shares determined by dividing $294,120 by the closing bid price of the Company’s common stock on the trading day immediately preceding the date on which the commitment fee is paid. Alternatively, the Company may pay $250,000 in cash prior to the due date. If not earlier paid, the commitment fee is payable in full on the six-month anniversary of the effective date of the Purchase Agreement.

The Company’s ability to submit a tranche notice is subject to certain conditions including, among others, that: (1) a registration statement covering our sale of shares of common stock issuable upon exercise of the additional investment right contained in the Purchase Agreement or upon exercise of the warrants issued to Socius in connection with the tranche is effective and (2) the issuance of such shares (together with all other shares beneficially owned) would not result in Socius and its affiliates beneficially owning more than 9.99% of the Company’s common stock.

 

13


7. Liability Settlements

On January 26, 2011 the Company issued 254,777 shares of common stock to Grenzebach Corporation (“Grenzebach”) and on February 2, 2011 the Company issued 290,323 shares of common stock to Reis GmbH & Co. KG Maschinenfabrik (“Reis”). These shares were issued in settlement of outstanding liabilities on the Company’s balance sheet of $3,137,870 and related to the purchase of certain pieces of equipment. The settlement of these obligations and issuance of common stock resulted in $850,000 in restructuring expenses during the three months ended March 31, 2011.

8. Subsequent Events

Bridge Financing

On April 27, 2011 the Company and two investors entered into Purchase Agreements (the “Purchase Agreements”). Pursuant to the Purchase Agreements, the investors agreed to loan the Company an aggregate of $250,000 for working capital purposes. In connection with these loans, the Company issued each investor a secured promissory note (each, a “Note”) and a warrant (each, a “Warrant”) to purchase shares of the Company’s common stock. The exercise price on the Warrants is $1.00 per share. The Notes are not convertible into common stock.

The original principal amount of the Notes and the number of shares subject to the Warrants are as follows:

 

Investor

   Original
Principal Amount
     Shares Subject
to Warrants
 

Investor Company in trust for Peter Lacey

   $ 125,000         250,000   

Michael Moretti

   $ 125,000         250,000   

Mr. Lacey is the Chairman of the Board of Directors and also the Company’s Interim President and Chief Executive Officer.

 

14


Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

The following discussion and analysis provides information that we believe is relevant to an assessment and understanding of our results of operation and financial condition. You should read this analysis in conjunction with our audited financial statements and related footnotes. This discussion and analysis contains statements of a forward-looking nature relating to future events or our future financial performance. These statements involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements, including those set forth in our Annual Report on Form 10-K filed on March 31, 2011 as well as Part II, Item 1A below.

Overview

We have developed a proprietary thin film deposition technology for solar photovoltaic (“PV”) products. We utilize a proprietary one-step sputter deposition process and have manufactured a commercial scale deposition tool to apply high-efficiency copper indium gallium diselenide (“CIGS”) material over large area glass substrates in a continuous fashion. We believe this proprietary tool, when combined with commercially available thin film manufacturing equipment, will provide a critically differentiated manufacturing process to produce low-cost monolithically integrated, CIGS-on-glass modules that address the grid-tied, ground-based PV market. We are pursuing a strategy to produce our CIGS-on-glass modules utilizing offshore manufacturing.

We believe this proprietary deposition process, when operated at an annual capacity of approximately 100 megawatts, will achieve a total module manufacturing cost of less than $1.00 per watt. This cost would be competitive with the lowest in the solar PV industry. Using this approach, we have achieved greater than 15% cell efficiencies over large areas on CIGS PV devices, and we believe that this approach will enable module efficiencies greater than 13%.

In October 2007, we completed a follow-on public offering in which we sold 17,250,000 shares of our common stock. Our net proceeds from the offering were approximately $68 million. We have used these proceeds to develop our proprietary deposition process, to build our prototype and commercial scale deposition tools. In the near term, we will require substantial funds beyond our current cash on hand in order to pursue a strategic partnership (or partnerships) to commercialize the CIGS modules, to pursue offshore manufacturing, to fund future operations, and to expand our capacity.

Critical Accounting Policies and Estimates

The preparation of our financial statements requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenue and expenses, and the related disclosures. A summary of those accounting policies can be found in the notes to our financial statements. Certain of our accounting policies are considered critical as they are both important to the portrayal of our financial condition and results of operations and require judgments on the part of management about matters that are uncertain. We have identified the following accounting policies that are important to the presentation of our financial condition and results of operations.

Property and Equipment. Property and equipment is stated at cost. Depreciation is computed using straight-line and an accelerated method over estimated useful lives of three to ten years. Expenditures for maintenance and repairs, which do not materially extend the useful lives of property and equipment, are charged to operations as incurred. When property or equipment is retired or otherwise disposed of, the property accounts are relieved of costs and accumulated depreciation and any resulting gain or loss is recognized.

Share-Based Compensation. We follow the provisions of FASB ASC 718 Compensation—Stock Compensation, which requires the measurement and recognition of compensation expense for all share-based payment awards to employees and directors based on estimated fair values. Additionally, we follow the SEC’s SAB No. 107, “Share-Based Payment” (“SAB 107”), as amended by SAB No. 110, which provides supplemental application guidance based on the views of the SEC.

Results of Operations

Comparison of the Three Months Ended March 31, 2011 and 2010

Certain reclassifications have been made to the 2010 financial information to conform to the 2011 presentation. Such reclassifications had no impact on net loss.

Research and development expenses. Research and development expenses were $606,565 for the three months ended March 31, 2011 compared to $2,488,828 for the three months ended March 31, 2010, a decrease of $1,882,263 or 76%. The decrease is primarily due to the cost savings measures implemented including a reduction in our workforce, the consolidation of our facilities into one location in California and a reduction in expenditures for materials, supplies and consultants, as well as a decrease in share based compensation.

 

15


Selling, general and administrative expenses. Selling, general and administrative expenses were $1,232,187 for the three months ended March 31, 2011 compared to $2,242,266 for the three months ended March 31, 2010, a decrease of $1,010,079 or 45%. The decrease in selling, general and administrative expenses was primarily due to cost savings measures implemented, including a reduction in our workforce and outside consultants and professional fees, as well as a decrease in share based compensation.

Restructuring. Restructuring expenses were $850,000 for the three months ended March 31, 2011. There were no restructuring expenses for the three months ended March 31, 2010. The restructuring expenses in 2011 resulted from impairment charges on certain equipment, as we have cancelled orders for such equipment and settled the outstanding obligations with the vendors. The settlement amounts which were paid in shares of our common stock was recorded as restructuring expense during the quarter.

Depreciation and amortization expense. Depreciation and amortization expense was $404,786 for the three months ended March 31, 2011 compared to $729,361 for the three months ended March 31, 2010, a decrease of $324,575 or 45%. During the second quarter of 2010, we consolidated our California facilities and recorded impairment charges on leasehold improvements and certain equipment which resulted in a decrease in depreciation expense.

Interest expense. Interest expense was $233,787 for the three months ended March 31, 2011 compared to $122,226 for the three months ended March 31, 2010, an increase of $111,561 or 91%. The increase in interest expense was due to the increase in our outstanding convertible notes issued in connection with our bridge financing, as well as interest expense on certain outstanding payables at March 31, 2011.

Amortization of note discount and financing costs. Amortization of note discount and financing costs was $705,812 for the three months ended March 31, 2011 compared to $975,231 for the three months ended March 31, 2010, a decrease of $269,419 or 28%. The convertible notes issued in connection with our bridge financing contain conversion features which result in discounts to the principal amount of the notes payable reflected on our balance sheet, based on the fair value of the conversion features. The discounts on the convertible notes are amortized using the effective interest method over the terms of the notes. During the first quarter of 2011 we amortized the remainder of the discount on the notes that were outstanding at the beginning of the quarter, whereas in the first quarter of 2010 we amortized a larger portion of the discount throughout the entire quarter.

Gain on derivative liabilities. Gain on derivative liabilities was $3,650,168 for the three months ended March 31, 2011 compared to $406,179 for the three months ended March 31, 2010. The conversion features on the convertible notes issued in conjunction with our bridge financing are considered derivative liabilities and are therefore required to be adjusted to fair value each quarter. A decrease in our stock price during the period results in a decrease in the liabilities and a gain on derivative liabilities. Conversely, an increase in our stock price during the period would result in an increase in the liabilities and a loss on derivative liabilities. During the three months ended March 31, 2011, our common stock price decreased which caused a decrease in the fair value of the conversion features, resulting in a gain on derivative liabilities. This decrease in stock price coupled with an increase in outstanding convertible notes resulted in a significant increase in gain on derivative liabilities for the three months ended March 31, 2011 as compared with the same quarter in 2010.

Liquidity and Capital Resources

At March 31, 2011, our cash and cash equivalents totaled $23,000 compared to $97,000 at December 31, 2010. Subsequent to March 31, 2011 and through May 16, 2011, we have received additional bridge financing of $250,000 to fund our operations.

We are in the development stage, and as such, have historically reported net losses, including a net loss of $0.4 million for the three months ended March 31, 2011. We anticipate incurring losses in the future, as we complete the commercialization of our products, invest in research and development, and incur associated administrative and operating costs. Our financial statements for the year ended December 31, 2010 and the three months ended March 31, 2011 have been prepared on a going concern basis, which contemplates the realization of assets and the settlement of liabilities and commitments in the normal course of business. As noted herein, as a result of our current liquidity, there is substantial doubt as to our ability to continue as a going concern.

We have historically financed our operations primarily from proceeds of the sale of equity securities and the issuance of convertible notes. We presently do not have any bank lines of credit that provide us with an additional source of debt financing. In order to fund the costs associated with our continued development and commercialization efforts, we completed a registered public offering during the fourth quarter of 2007 in which we sold 1,916,667 shares of our common stock at $38.25 per share and generated net proceeds of approximately $68 million after deducting underwriting discounts and the fees and expenses of the offering. Upon receipt of the proceeds from the offering, we re-paid in full $9.2 million of existing indebtedness. We have used these proceeds to develop our proprietary deposition process and to build our prototype and commercial scale deposition tools. We are pursuing a strategy to commercialize and manufacture our CIGS modules offshore and are in discussions with potential partners to implement this strategy. Commercialization efforts, including continued development and administrative costs will require significant additional capital.

 

16


Beginning in September 2009, we have funded our operations through a series of bridge financing transactions in which we have issued convertible and traditional notes with an aggregate principal amount of $5,655,000 and also issued warrants exercisable for shares of our common stock. Currently, $4,505,000 of these notes remains outstanding.

In order to address our immediate capital requirements, in February 2011, we entered into a Securities Purchase Agreement with Socius CG II, Ltd. (the “Investor” or “Socius”). Pursuant to the terms of the Purchase Agreement, we have the right over a term of two years, subject to certain conditions, to demand through separate tranche notices that the Investor purchase up to a total of $5.0 million of Series B preferred stock. However, in order to continue operations, including development and commercialization efforts, we will require substantial additional capital beyond our current cash on hand and any funds received from the Socius transaction. We are seeking long-term strategic investments and partnerships to manufacture and commercialize our product. To date, we have been unable to raise substantial additional capital or complete an agreement with a strategic partner. Although we continue to seek strategic investors or partners, in light of our current cash position, we may in the near term be forced to cease or further curtail operations.

An inability to raise additional funding in the very near term may cause us to file a voluntary petition for reorganization under the United States Bankruptcy Code, liquidate assets, and/or pursue other such actions that could adversely affect future operations. A wide variety of factors relating to the Company including those described in the section entitled “Risk Factors” in Part I Item 1A in our Annual Report on Form 10-K, as well as external conditions, could adversely affect our ability to secure additional funding necessary to continue operations and the terms of any funding that we secure.

Commitments. At March 31, 2011, we had no outstanding purchase orders for equipment and improvements. Other commitments include rental payments under operating leases for office space and equipment, and commitments under employment contracts with our executive officers. These commitments are discussed further in the Commitments and Contingencies footnote to our financial statements in our Annual Report on Form 10-K.

Off-Balance Sheet Arrangements. The only off-balance sheet obligations are for operating leases and certain other commitments entered into in the ordinary course of business.

We lease 32,000 square feet of factory and office space in Milpitas, California under a lease which expires in May 2011. This facility is the location of our corporate headquarters as well as the development of our products and proprietary deposition equipment. We are currently in the process of negotiating an extension of this lease.

 

Item 3. Quantitative and Qualitative Disclosures about Market Risk

Our exposure to market risk for a change in interest rates relates primarily to interest earned on our cash and cash equivalents balance. We maintain our portfolio in high credit quality cash deposits and money market funds that invest in Treasury instruments with carrying values that approximate market value. Due to the short duration of our investment portfolio, we do not expect that a 10% change in interest rates would have a material effect on the fair market value of our cash and cash equivalents.

We also have market risk arising from changes in foreign currency exchange rates related to expenses and/or equipment we purchase from foreign businesses. Our payments related to these purchases may be denominated in foreign currency. We believe that such exposure does not present a significant risk due to the limited number of transactions and/or accounts payable denominated in foreign currency. Consequently, we do not believe that a 10% change in foreign currency exchange rates would have a significant effect on our future net income or cash flows.

 

Item 4. Controls and Procedures

Evaluation of Disclosure Controls and Procedures

We maintain disclosure controls and procedures that are designed to ensure that information required to be disclosed in our reports pursuant to the Securities Exchange Act of 1934, as amended (the “Exchange Act”), is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms, and that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure. In designing and evaluating the disclosure controls and procedures, management recognizes that any controls and procedures, no matter how well designed and utilized, can provide only reasonable assurance of achieving the desired control objectives, and management necessarily is required to apply its judgment in evaluating disclosure controls and procedures.

As required by Rule 13a-15(b) or Rule 15d-15(b) under the Exchange Act, we carried out an evaluation, under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, of the effectiveness of our disclosure controls and procedures, as defined in Rule 13a-15(e) or Rule 15d-15(e) under the Exchange Act, as of the end of the period covered by this report. Based on the foregoing, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures were effective as of March 31, 2011.

 

17


Changes in Internal Control Over Financial Reporting

There were no changes in our internal control over financial reporting during the quarter ended March 31, 2011 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

PART II. OTHER INFORMATION

 

Item 1. Legal Proceedings

In the ordinary conduct of our business, we are subject to periodic lawsuits, investigations and claims, including routine employment matters. The following is a summary of legal proceedings to which we are a party at this time.

On January 6, 2010, New York State Urban Development, d/b/a/ Empire State Development Corporation (“ESDC”), filed a breach of contract action against us. This action stems from the Grant Disbursement Award we entered into with ESDC when we relocated our headquarters to New York in 2004. ESDC has been awarded a judgment of approximately $520,000 and is currently in the process of enforcing its judgment to recover such damages.

 

Item 1A. Risk Factors

Item 1A (“Risk Factors”) of our annual report on Form 10-K for our fiscal year ended December 31, 2010 (“Annual Report”) sets forth information relating to important risks and uncertainties that could materially adversely affect our business, financial condition or operating results. The risks and uncertainties described in our Annual Report do not constitute all the risk factors that pertain to our business but we do believe that they reflect the more important ones. Accordingly, you should review and consider such Risk Factors in making any investment decision with respect to our securities. An investment in our securities continues to involve a high degree of risk. There have been no material changes in the Risk Factors contained in our Annual Report.

 

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

Bridge Financing. On January 24, 2011we entered into a Purchase Agreement (the “Purchase Agreement”) with Michael Moretti. Pursuant to the Purchase Agreement, Mr. Moretti agreed to loan us the amount of $150,000 (the “Loan”) to fund ongoing research and development and related business operations. On January 24, 2011, we issued Mr. Moretti (a) a Secured Convertible Promissory Note (the “Note”) and (b) a warrant to purchase 193,550 shares of our common stock (subject to adjustment for certain dilutive transactions) (the “Warrant”). The Note carries an interest rate of 10% per annum and is initially convertible into 96,775 shares of our common stock based on a $1.55 conversion price. The Note matures on July 23, 2011, is secured by all of our assets, and includes customary provisions concerning events of default. The Warrant is immediately exercisable, has a term of five years, and has an exercise price of $1.55 per share.

Settlement with Equipment Vendors. In July 2008, we entered into a Purchase Order with Grenzebach Corporation (“Grenzebach”) for the purchase of a several pieces of equipment (collectively “Equipment”). On January 26, 2011, we entered into a Settlement Agreement and Mutual Release with Grenzebach, whereby we issued Grenzebach 254,777 shares of our common stock in exchange for a release of any and all claims that may be related to the Purchase Order or the Equipment. The shares were issued in a transaction exempt from registration under Section 4(2) of the Securities Act of 1933, as amended.

In July 2008, we entered into a Purchase Order with Reis GmbH & Co. KG Maschinenfabrik (“Reis”) for the purchase of several pieces of equipment (collectively “Equipment”). On February 2, 2011, we entered into a Settlement Agreement and Mutual Release with Reis, whereby we issued Reis 290,323 shares of our common stock in exchange for a release of any and all claims that may be related to the Purchase Order or the Equipment. The shares were issued in a transaction exempt from registration under Section 4(2) of the Securities Act of 1933, as amended.

We entered into Registration Rights Agreements with Mr. Moretti, Grenzebach and Reis whereby we are required to register all shares underlying the convertible notes and warrants and the settlement agreements.

 

Item 3. Defaults Upon Senior Securities.

None.

 

Item 4. (Removed and Reserved).

None.

 

Item 5. Other Information.

(a) None.

(b) None.

 

18


Item 6. Exhibits

(a) The following exhibits are filed as part of this report:

 

    Exhibit    

No.

 

Description

     3.1(1)

  Amended and Restated Certificate of Incorporation.

     3.2(2)

  Certificate of Amendment of Amended and Restated Certificate of Incorporation.

     3.3(3)

  Amended and Restated Bylaws.

     3.4(4)

  Text of Amendment of Amended and Restated Bylaws

     3.5(5)

  Certificate of Designations, Preferences and Rights of a Series of Preferred Stock classifying and designating the Series A Junior Participating Cumulative Preferred Stock.

     4.1(5)

  Stockholder Rights Agreement, dated as of May 6, 2008 between the Company and Computershare Trust Company, N.A., as Rights Agent.

     4.2(6)

  Form of Common Stock Certificate.

     4.3(6)

  Form of Class A Public Warrant.

     4.4(6)

  Form of Class B Public Warrant.

     4.5(6)

  Form of Unit Certificate.

     4.6(6)

  Form of Warrant Agent Agreement.

     4.7(6)

  Form of Representative’s Warrant.

31.1

  Certification of Chief Executive Officer pursuant to Rule 13a-14(a) under the Securities Exchange Act of 1934.

31.2

  Certification of Chief Financial Officer pursuant to Rule 13a-14(a) under the Securities Exchange Act of 1934.

32.1

  Certification of the Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

32.2

  Certification of the Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

 

(1) Incorporated by reference to our Quarterly Report on Form 10-QSB filed with the SEC on August 11, 2006.
(2) Incorporated by reference to our Quarterly Report on Form 10-Q filed with the SEC on November 14, 2008.
(3) Incorporated by reference to our Quarterly Report on Form 10-Q filed with the SEC on August 7, 2008.
(4) Incorporated by reference to our Current Report on Form 8-K filed with the SEC on January 25, 2010.
(5) Incorporated by reference to our Registration Statement on Form 8-A filed with the SEC on May 8, 2008.
(6) Incorporated by reference to our Registration Statement on Form SB-2 filed with the SEC on November 7, 2003.

 

19


SIGNATURES

In accordance with the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

    DAYSTAR TECHNOLOGIES, INC.
Date: May 16, 2011     By:  

/S/    PETER A. LACEY        

      Peter A. Lacey
      Interim Chief Executive Officer (Principal Executive Officer)
Date: May 16, 2011     By:  

/S/    CHRISTOPHER T. LAIL        

      Christopher T. Lail
      Chief Financial Officer (Principal Financial & Accounting Officer)

 

20


EXHIBIT INDEX

 

    Exhibit    

No.

 

Description

     3.1(1)

  Amended and Restated Certificate of Incorporation.

     3.2(2)

  Certificate of Amendment of Amended and Restated Certificate of Incorporation.

     3.3(3)

  Amended and Restated Bylaws.

     3.4(4)

  Text of Amendment of Amended and Restated Bylaws

     3.5(5)

  Certificate of Designations, Preferences and Rights of a Series of Preferred Stock classifying and designating the Series A Junior Participating Cumulative Preferred Stock.

     4.1(5)

  Stockholder Rights Agreement, dated as of May 6, 2008 between the Company and Computershare Trust Company, N.A., as Rights Agent.

     4.2(6)

  Form of Common Stock Certificate.

     4.3(6)

  Form of Class A Public Warrant.

     4.4(6)

  Form of Class B Public Warrant.

     4.5(6)

  Form of Unit Certificate.

     4.6(6)

  Form of Warrant Agent Agreement.

     4.7(6)

  Form of Representative’s Warrant.

31.1

  Certification of Chief Executive Officer pursuant to Rule 13a-14(a) under the Securities Exchange Act of 1934.

31.2

  Certification of Chief Financial Officer pursuant to Rule 13a-14(a) under the Securities Exchange Act of 1934.

32.1

  Certification of the Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

32.2

  Certification of the Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

 

(1) Incorporated by reference to our Quarterly Report on Form 10-QSB filed with the SEC on August 11, 2006.
(2) Incorporated by reference to our Quarterly Report on Form 10-Q filed with the SEC on November 14, 2008.
(3) Incorporated by reference to our Quarterly Report on Form 10-Q filed with the SEC on August 7, 2008.
(4) Incorporated by reference to our Current Report on Form 8-K filed with the SEC on January 25, 2010.
(5) Incorporated by reference to our Registration Statement on Form 8-A filed with the SEC on May 8, 2008.
(6) Incorporated by reference to our Registration Statement on Form SB-2 filed with the SEC on November 7, 2003.

 

21